Stock 300267 HUNAN ER-KANG PHARMACEUTICAL CO., LTD
Add to a list
To use this feature you must be a member
Log inSign up

Company Hunan Er-Kang Pharmaceutical Co., Ltd

Equities

300267

CNE100001781

Pharmaceuticals

End-of-day quote Shenzhen S.E.
Other stock markets
 23:00:00 16/05/2024 BST 		5-day change 1st Jan Change
2.61 CNY 0.00% Intraday chart for Hunan Er-Kang Pharmaceutical Co., Ltd -6.12% -18.69%
04-26 Hunan Er-Kang Pharmaceutical Co., Ltd Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
04-24 Hunan Er-Kang Pharmaceutical Co., Ltd Reports Earnings Results for the Full Year Ended December 31, 2023 CI

Business Summary

HUNAN ER-KANG PHARMACEUTICAL CO., LTD. is principally engaged in the research, development, production and sales of pharmaceutical excipients, finished drugs and bulk drugs. The Company’s pharmaceutical excipients mainly consist of glycerol for medicine, sugar for medicine, ethanol for medicine, propylene glycol for medicine, as well as sodium hydroxide for medicine and others. Its bulk drugs consist of sulfadiazine, sulphaguanidine and resorcinol, among others. Its finished drugs consist of sulbenicillin sodium injections and compound liquorice tablets. The Company distributes its products in domestic market and to overseas markets.

Number of employees: 1,497

Sales per Business

CNY in Million2022Weight2023Weight Delta
Accessories
73.8 %
1,169 62.5 % 1,315 73.8 % +12.57%
Raw Materials
16.3 %
479 25.6 % 291 16.3 % -39.29%
Finished Medicine
7.1 %
137 7.3 % 127 7.1 % -7.21%
New Energy Materials
1.7 %
- - 30 1.7 % -
Other
1.1 %
86 4.6 % 20 1.1 % -77.03%

Sales per region

CNY in Million2022Weight2023Weight Delta
China
84.1 %
1,423 76.1 % 1,500 84.1 % +5.44%
Overseas
15.9 %
448 23.9 % 283 15.9 % -36.80%

Managers

Managers TitleAgeSince
Qingrong Sun CEO
 Chief Executive Officer 38 13/11/19
Fang Wen Shuai FOU
 Founder 58 21/10/03
Xun Zhao DFI
 Director of Finance/CFO 36 -
Hai Ming Yang CTO
 Chief Tech/Sci/R&D Officer 54 31/12/06
Li Cheng Zhang BRD
 Director/Board Member 45 30/09/05
Jishun Gu PRN
 Corporate Officer/Principal 58 19/03/20

Members of the board

Members of the board TitleAgeSince
Fang Wen Shuai FOU
 Founder 58 21/10/03
Li Cheng Zhang BRD
 Director/Board Member 45 30/09/05
Hai Ming Yang CTO
 Chief Tech/Sci/R&D Officer 54 31/12/06
Yi Guo Li BRD
 Director/Board Member 59 31/12/11
Tian Fang Zuo BRD
 Director/Board Member 59 -
Xun Zhao DFI
 Director of Finance/CFO 36 -
Yang Qi BRD
 Director/Board Member - -
Wuzhen Jiang BRD
 Director/Board Member 52 13/11/19
Junwen Wang BRD
 Director/Board Member - 08/12/19
Qing Peng CHM
 Chairman 53 19/05/21

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 2,062,604,870 934,204,722 ( 45.29 %) 0 45.29 %

Shareholders

NameEquities%Valuation
Fang Wen Shuai
15.09 %
213,393,727 15.09 % 76 M ¥
Hunan Shuaijia Investment Co. Ltd.
9.399 %
132,951,004 9.399 % 47 M ¥
Xing Ni Peng
3.706 %
52,427,048 3.706 % 19 M ¥
Zhe Xia
3.186 %
45,071,174 3.186 % 16 M ¥
Hunan Jinyang Investment Group Co., Ltd.
2.020 %
28,570,000 2.020 % 10 M ¥
Zhuang Yu Li
1.493 %
21,121,018 1.493 % 7 M ¥
Xi De Yang
1.032 %
14,600,098 1.032 % 5 M ¥
Foshan Yilu Wuyou Trading Co. Ltd.
0.6900 %
9,760,800 0.6900 % 3 M ¥
Liang Guo Xu
0.5143 %
7,275,100 0.5143 % 3 M ¥
Hunan ER Kang Pharmaceutical Co. Ltd. ESOP
0.4242 %
6,000,170 0.4242 % 2 M ¥
NameEquities%Valuation
Fang Wen Shuai
99.69 %
640,181,179 99.69 % 227 M ¥

Company contact information

Hunan Er-Kang Pharmaceutical Co., Ltd.

Liuyang Economic & Development Zone No. 167 Kangping Road

410331, Changsha

+86 731 8465 9108

http://www.hnerkang.com
address Hunan Er-Kang Pharmaceutical Co., Ltd(300267)

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Other Pharmaceuticals

Sales per Business

Sales per region

Sector Other Pharmaceuticals

1st Jan change Capi.
HUNAN ER-KANG PHARMACEUTICAL CO., LTD Stock Hunan Er-Kang Pharmaceutical Co., Ltd
-18.69% 745M
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+32.09% 693B
NOVO NORDISK A/S Stock Novo Nordisk A/S
+29.39% 584B
JOHNSON & JOHNSON Stock Johnson & Johnson
-1.34% 372B
MERCK & CO., INC. Stock Merck & Co., Inc.
+20.34% 332B
ABBVIE INC. Stock AbbVie Inc.
+7.39% 294B
ASTRAZENECA PLC Stock AstraZeneca PLC
+14.25% 239B
ROCHE HOLDING AG Stock Roche Holding AG
-3.03% 211B
NOVARTIS AG Stock Novartis AG
+10.02% 210B
AMGEN INC. Stock Amgen Inc.
+8.49% 168B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. 300267 Stock
  4. Company Hunan Er-Kang Pharmaceutical Co., Ltd